Aller au contenu

514 606-3350

info@cliniqueomicron.ca​

FR / EN
Logo - Clinique Omicron
Make an appointment
Obstetrics & Maternal-Fetal Medicine & Family Medicine

Preeclampsia (pregnancy toxemia)

Obtenir un avis adapté à votre situation

Consultation en clinique ou en téléconsultation, partout au Québec.

Pre-eclampsia - formerly known as toxemia gravidarum - is a pregnancy-specific syndrome characterized by the onset of de novo arterial hypertension (AH) after the 20th week of amenorrhea (SA) associated with significant proteinuria + or signs of target organ dysfunction (kidney + liver + brain + lung + placenta + platelets) in a previously normotensive woman, constituting one of the leading causes of maternal and perinatal mortality and morbidity worldwide. With an incidence of 2 to 8 % of pregnancies in Canada + preeclampsia complicates thousands of Quebec pregnancies every year, and represents an obstetrical emergency whose only definitive cure is delivery - the placenta being the central organ of the pathophysiology. The pathophysiology is an anomaly in trophoblast development: insufficient trophoblastic invasion of maternal spiral arteries during placentation (1st and early 2nd trimester) → spiral arteries remain at high flow resistance → placental hypoxia → release of circulating antiangiogenic factors (sFlt-1 - soluble FMS-like tyrosine kinase 1 + sEng - soluble endoglin) → inhibition of VEGF and PlGF signaling → systemic endothelial dysfunction → vasospasm + increased vascular permeability + activation of coagulation → HTA + proteinuria + edema + multi-organ damage. Women with pre-eclampsia subsequently have a significantly increased long-term cardiovascular risk (risk × 2-4 of chronic hypertension + myocardial infarction + stroke + type 2 diabetes) - making pre-eclampsia an important marker of maternal cardiovascular risk to consider in long-term post-partum follow-up.

Classification of hypertensive disorders in pregnancy

Type Definition Features
Gestational hypertension PAS ≥ 140 mmHg or PAD ≥ 90 mmHg after 20 SA + without proteinuria or organ dysfunction Isolated hypertension without other preeclampsia criteria + may precede preeclampsia → monitor closely
Preeclampsia without signs of severity HTA (PAS ≥ 140 or PAD ≥ 90) after 20 SA + proteinuria ≥ 300 mg/24 h (or pro/creat ratio ≥ 30 mg/mmol) hypertension + proteinuria + no severe organ damage + close monitoring
Severe preeclampsia Preeclampsia + ≥ 1 severity criterion (see below) Indication for delivery according to gestational age + magnesium sulfate mandatory
Eclampsia Tonic-clonic convulsions occurring in the context of preeclampsia and not explained by another cause Neurological and obstetrical emergency + immediate IV magnesium sulfate + urgent delivery
HELLP syndrome Hemolysis + elevated LDH + elevated AST + platelets < 100,000/µL Severe complication → see dedicated data sheet
Chronic hypertension with added preeclampsia Pre-existing hypertension + onset or worsening of proteinuria after 20 weeks' gestation Worse prognosis than normotensive preeclampsia

Pre-eclampsia severity criteria

  • Severe hypertension : PAS ≥ 160 mmHg + or PAD ≥ 110 mmHg on two occasions ≥ 4 hours apart
  • Kidney damage : creatinine ≥ 97 µmol/L (or doubling of baseline creatinine) + or oliguria (< 500 mL/24 h)
  • Liver damage : ASAT or ALAT > 2× LSN + or severe and persistent epigastric or right hypochondrium pain unresponsive to analgesics
  • Neurological damage : persistent severe headaches resistant to analgesics + visual disturbances (scotomas + diplopia + cortical blindness) + sharp osteotendinous reflexes + neuromuscular hyperexcitability (prodromal eclampsia)
  • Lung involvement : pulmonary edema
  • Hematological disorders : thrombocytopenia < 100 000/µL + DIC
  • Fetal damage : severe intrauterine growth retardation + severe oligohydramnios + pathological umbilical Doppler (absent or inverted diastole)

Risk factors and aspirin prevention

  • High-risk factors (≥ 1 factor → aspirin recommended) : antecedent preeclampsia (risk × 8) + multiple pregnancy + chronic hypertension + diabetes (type 1 or 2) + chronic kidney disease + antiphospholipid syndrome + lupus + primiparous with ≥ 2 moderate factors
  • Moderate risk factors: primiparous + obese (BMI > 30) + family history of 1st-degree preeclampsia + age ≥ 35 years + inter-pregnancy interval > 10 years + IVF pregnancy
  • Low-dose aspirin (81 mg/d): initiated between 12 and 16 SA (ideally before 16 SA) + taken in the evening at bedtime + continued until 36 SA + reduced risk of preeclampsia by 17-24 % in the general population + and up to 62 % in high-risk pregnancies + mechanism: inhibition of platelet TxA2 → reduced vasospasm + improved uteroplacental perfusion
  • Calcium : calcium supplementation 1.5-2 g/day for women with inadequate dietary calcium intake → reduces risk of preeclampsia + especially in low-income countries
  • Combined 1st trimester screening (11-14 SA) : serum markers (PlGF - placental growth factor + PAPP-A) + uterine artery Doppler + BP + BMI → calculation of risk of early preeclampsia (< 34 SA) → sensitivity 90 % with 10 % false positives → guides aspirin prescription

Support

  • Preeclampsia without signs of severity (34-37 SA) : hospitalization + close maternal and fetal monitoring + antihypertensives if BP persists ≥ 140/90 → labetalol per os (100-400 mg × 2-3/d) + or nifedipine LP + target BP < 140/90 + DO NOT aim for too low a BP (risk of placental hypoperfusion) + delivery at 37 SA recommended (HYPITAT trial)
  • Severe preeclampsia (< 34 SA) : hospitalization in a level 3 center + magnesium sulfate IV (4-6 g loading + 1-2 g/h maintenance) + antihypertensives IV (labetalol IV + or hydralazine + or rapid oral nifedipine) + corticoids (betamethasone 12 mg IM × 2 if < 34 SA for lung maturation) + continuous fetal monitoring + delivery decision based on maternal and fetal benefit/risk balance according to gestational age
  • Severe preeclampsia (≥ 34 SA) : delivery after BP stabilization + administration of magnesium + corticosteroids if < 37 SA
  • Antihypertensives contraindicated in pregnancy : ACE inhibitors + ARB II (teratogenic in the 2nd and 3rd trimesters - renal malformations + fetal anuria) → use labetalol + nifedipine + methyldopa + hydralazine
  • Magnesium sulfate - prevention and treatment of eclampsia : 4-6 g IV in 15-20 min (loading) + 1-2 g/h (maintenance) + monitoring: FR (> 12/min) + ROT (present) + diuresis (> 25 mL/h) + magnesemia (target 2-3.5 mmol/L) + antidote: calcium gluconate 1 g IV
  • Post-partum monitoring and treatment : BP may worsen in the 48-72 h postpartum + maintain antihypertensive drugs + monitor BP + platelets + creatinine + transaminases for at least 48-72 h + breastfeeding compatible with labetalol + nifedipine + methyldopa
ℙ️ Low-dose aspirin (81 mg/d in the evening) initiated before 16 weeks of pregnancy is the most effective preventive intervention against early and severe preeclampsia in high-risk women - with a reduction of up to 62 % in high-risk pregnancies according to the ASPRE trial (2017). It is most effective when started before 16 weeks' gestation. Any woman with a history of preeclampsia + multiple pregnancy + chronic hypertension + pre-existing diabetes + renal disease + or SAPL should receive aspirin 81 mg/d as soon as pregnancy is confirmed.
Obstetrical emergency - dial 911

Call 911 or go immediately to the obstetric emergency room if a pregnant woman (or one who has given birth within 7 days) presents with severe headaches + visual disturbances (spots + flashes + visual blur) + epigastric pain + sudden swelling of the face or hands + or convulsions - these signs suggest severe preeclampsia or eclampsia requiring emergency management. For the prescription of preventive aspirin in early pregnancy and prenatal blood pressure monitoring, Clinique Omicron offers consultations at its points of service in Quebec and via telemedicine. To book an appointment, visit cliniqueomicron.ca.

Consult at Clinique Omicron

Clinique Omicron's specialized physicians and nurse practitioners (NPs) assess preeclampsia risk factors at the first prenatal check-up, prescribe aspirin 81 mg/d before 16 weeks' amenorrhea for high-risk women, measure and monitor blood pressure at every prenatal visit, screen for proteinuria by urine dipstick or urine protein/creatinine ratio, refer immediately to level 3 obstetrics in cases of suspected severe pre-eclampsia, and provide long-term post-partum cardiovascular follow-up for women who have had pre-eclampsia. Consultations are available at several points of service in Quebec, as well as via telemedicine. To book an appointment, visit cliniqueomicron.ca.

The contents of this page are provided for information purposes only and do not replace the advice of a physician or obstetrician. ACE inhibitors and ARB IIs are formally contraindicated in pregnancy. Preventive aspirin must be started before 16 weeks' gestation to be effective - starting it after 16 weeks' gestation significantly reduces its preventive benefit. Women who have had pre-eclampsia have an increased long-term cardiovascular risk and should be monitored annually.

Omicron Clinic

Need to consult a doctor?

En clinique ou en télémédecine, partout au Québec.

Reçus pour assurances. Téléconsultation 7 j/7. Sans médecin de famille requis.

Skip to content